Skip to main content

Table 2 Changes in blood glucose and plasma insulin levels of control and experimental animals

From: Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats

Groups fasting blood glucose (mg/dL) Plasma insulin (μU / mL)
Normal 81.58 ± 2.40a 11.18 ± 0.74 a
Normal 81.58 ± 2.40a 11.18 ± 0.74 a
Diabetic control 265.00 ± 24.40b 3.55 ± 0.38 c
Diabetic + Diasulin (50 mg/kg) 210.80 ± 14.26c 5.61 ± 0.48d
Diabetic + Diasulin (100 mg/kg) 158.33 ± 11.00d 6.03 ± 0.41d
Diabetic + Diasulin (200 mg/kg) 104.16 ± 6.70e 7.05 ± 0.64e
Diabetic + Glibenclamide (600 μg/kg) 111.60 ± 9.86e 6.32 ± 0.55de
  1. Values are given as mean ± S.D for 6 rats in each group.
  2. Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
  3. Duncan procedure, Range for the level 2.89, 3.03, 3.13, 3.20, 3.25.
  4. Diabetic control was compared with normal, p < 0.001.
  5. Experimental groups were compared with diabetic control, * p < 0.001.+ + +, > 2% sugar, ++; -2% sugar; +, -1%